Détails
- Fabricant
- Future Health Pharma GmbH
- Code ATC
- J07AE01
- Statut
- 1 aktuell keine Lieferungen
- Signalé depuis
- 22 jours
- Livraison prévue
- Delivery is expected towards the end of 2026
- Premier signalement
- 01.01.2026
- Signalé par
- Firma
- Principe actif
- vibrio cholerae O1 Inaba 6973 biotipus El Tor inactivatus (formaldehydum), vibrio cholerae O1 Inaba 48 Classical Biotyp inactivatus (calor), vibrio cholerae O1 Ogawa 50 Classical Biotyp inactivatus (calor), vibrio cholerae O1 Ogawa 50 Classical Biotyp inactivatus (formaldehydum), toxinum cholerae subunitatis B recombinatum (rCTB-213)
- N° Swissmedic
- 70403
- Information professionnelle (AIPS)
- swissmedicinfo.ch →
Composition
Vaccinum attenuatum per os: vibrio cholerae O1 Inaba 6973 biotipus El Tor inactivatus (formaldehydum) 31.25 Mia. U., vibrio cholerae O1 Inaba 48 Classical Biotyp inactivatus (calor) 31.25 Mia. U., vibrio cholerae O1 Ogawa 50 Classical Biotyp inactivatus (calor) 31.25 Mia. U., vibrio cholerae O1 Ogawa 50 Classical Biotyp inactivatus (formaldehydum) 31.25 Mia. U., toxinum cholerae subunitatis B recombinatum (rCTB-213) 1 mg, natrii chloridum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile, ad suspensionem pro 3 ml. Pulver: natrii hydrogenocarbonas, acidum citricum, aromatica (Himbeere) cum maltodextrinum, saccharinum natricum, natrii carbonas, natrii citras dihydricus, ad pulverem pro 5.6 g. Suspensio reconstituta: suspensio reconstituta corresp. natrium ca. 1.2 g.
Source : drugshortage.ch · sans garantie d'exhaustivité